Pharma & Healthcare
Global Celecoxib Market Research Report 2025
- Apr 16, 25
- ID: 188093
- Pages: 86
- Figures: 84
- Views: 32
The global market for Celecoxib was valued at US$ 1492 million in the year 2024 and is projected to reach a revised size of US$ 2604 million by 2031, growing at a CAGR of 8.4% during the forecast period.
Celecoxib capsules (patent brand name: CELEBREX), is a new generation of non-steroidal anti-inflammatory and analgesic drugs, mainly through the selective inhibition of coX-2 (COX-2) to inhibit the production of prostaglandins, achieve anti-inflammatory and analgesic effects.
The drug is used to relieve symptoms and signs of osteoarthritis and rheumatoid arthritis in adults and has fewer gastrointestinal side effects than traditional non-steroidal anti-inflammatory drugs.
Data show that more than 400 million people worldwide are currently affected by joint diseases.
The prevalence of osteoarthritis is 17 percent among people aged 40, 62 percent among people over 60 and 80 percent among people over 75.
The number of patients with arthritis in mainland China is more than 10% of the total population, well over 100 million, and the incidence of arthritis increases with age, and the number of patients is still increasing.
At present, the burden of chronic diseases will increase by 40% due to the aging of the population.
As the population ages, anti-inflammatory and anti-rheumatic drugs will enter a phase of rapid growth.
Globally, whether prescription drugs or non-prescription drugs, Xibu is widely used in clinical practice.
At present, the best seller in the international market is Celixib. Celixib market will continue to grow steadily in the next few years.
At present, the global Celecoxib market is basically occupied by Pfizer, which has formed an oligopoly.
It accounted for 63.39% of the global market in 2019.
As of 2019, China relies entirely on Pfizer for celecoxib imports.
Since 2020, some domestic drug companies have been gradually approved by FDA and CFDA. The introduction of celecoxib generic drugs by local companies will break the monopoly of import.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Celecoxib, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Celecoxib.
The Celecoxib market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Celecoxib market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Celecoxib manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Pfizer Inc
Teva
Mylan
Apotex
Lupin
Hengrui Medicine
Segment by Type
50mg
100mg
200mg
400mg
Segment by Application
Rheumatoid arthritis
osteoarthritis
Acute pain
Musculoskeletal pain
Other diseases
Consumption by Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Celecoxib manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Celecoxib in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Celecoxib capsules (patent brand name: CELEBREX), is a new generation of non-steroidal anti-inflammatory and analgesic drugs, mainly through the selective inhibition of coX-2 (COX-2) to inhibit the production of prostaglandins, achieve anti-inflammatory and analgesic effects.
The drug is used to relieve symptoms and signs of osteoarthritis and rheumatoid arthritis in adults and has fewer gastrointestinal side effects than traditional non-steroidal anti-inflammatory drugs.
Data show that more than 400 million people worldwide are currently affected by joint diseases.
The prevalence of osteoarthritis is 17 percent among people aged 40, 62 percent among people over 60 and 80 percent among people over 75.
The number of patients with arthritis in mainland China is more than 10% of the total population, well over 100 million, and the incidence of arthritis increases with age, and the number of patients is still increasing.
At present, the burden of chronic diseases will increase by 40% due to the aging of the population.
As the population ages, anti-inflammatory and anti-rheumatic drugs will enter a phase of rapid growth.
Globally, whether prescription drugs or non-prescription drugs, Xibu is widely used in clinical practice.
At present, the best seller in the international market is Celixib. Celixib market will continue to grow steadily in the next few years.
At present, the global Celecoxib market is basically occupied by Pfizer, which has formed an oligopoly.
It accounted for 63.39% of the global market in 2019.
As of 2019, China relies entirely on Pfizer for celecoxib imports.
Since 2020, some domestic drug companies have been gradually approved by FDA and CFDA. The introduction of celecoxib generic drugs by local companies will break the monopoly of import.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Celecoxib, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Celecoxib.
The Celecoxib market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Celecoxib market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Celecoxib manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Pfizer Inc
Teva
Mylan
Apotex
Lupin
Hengrui Medicine
Segment by Type
50mg
100mg
200mg
400mg
Segment by Application
Rheumatoid arthritis
osteoarthritis
Acute pain
Musculoskeletal pain
Other diseases
Consumption by Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Celecoxib manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Celecoxib in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
1 Celecoxib Market Overview
1.1 Product Definition
1.2 Celecoxib by Type
1.2.1 Global Celecoxib Market Value Comparison by Type (2024 VS 2031)
1.2.2 50mg
1.2.3 100mg
1.2.4 200mg
1.2.5 400mg
1.3 Celecoxib by Application
1.3.1 Global Celecoxib Market Value by Application (2024 VS 2031)
1.3.2 Rheumatoid arthritis
1.3.3 osteoarthritis
1.3.4 Acute pain
1.3.5 Musculoskeletal pain
1.3.6 Other diseases
1.4 Global Celecoxib Market Size Estimates and Forecasts
1.4.1 Global Celecoxib Revenue 2020-2031
1.4.2 Global Celecoxib Sales 2020-2031
1.4.3 Global Celecoxib Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Celecoxib Market Competition by Manufacturers
2.1 Global Celecoxib Sales Market Share by Manufacturers (2020-2025)
2.2 Global Celecoxib Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Celecoxib Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Celecoxib, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Celecoxib, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Celecoxib, Product Type & Application
2.7 Global Key Manufacturers of Celecoxib, Date of Enter into This Industry
2.8 Global Celecoxib Market Competitive Situation and Trends
2.8.1 Global Celecoxib Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Celecoxib Players Market Share by Revenue
2.8.3 Global Celecoxib Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Celecoxib Market Scenario by Region
3.1 Global Celecoxib Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Celecoxib Sales by Region: 2020-2031
3.2.1 Global Celecoxib Sales by Region: 2020-2025
3.2.2 Global Celecoxib Sales by Region: 2026-2031
3.3 Global Celecoxib Revenue by Region: 2020-2031
3.3.1 Global Celecoxib Revenue by Region: 2020-2025
3.3.2 Global Celecoxib Revenue by Region: 2026-2031
3.4 North America Celecoxib Market Facts & Figures by Country
3.4.1 North America Celecoxib Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Celecoxib Sales by Country (2020-2031)
3.4.3 North America Celecoxib Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Celecoxib Market Facts & Figures by Country
3.5.1 Europe Celecoxib Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Celecoxib Sales by Country (2020-2031)
3.5.3 Europe Celecoxib Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Celecoxib Market Facts & Figures by Region
3.6.1 Asia Pacific Celecoxib Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Celecoxib Sales by Region (2020-2031)
3.6.3 Asia Pacific Celecoxib Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Celecoxib Market Facts & Figures by Country
3.7.1 Latin America Celecoxib Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Celecoxib Sales by Country (2020-2031)
3.7.3 Latin America Celecoxib Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Celecoxib Market Facts & Figures by Country
3.8.1 Middle East and Africa Celecoxib Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Celecoxib Sales by Country (2020-2031)
3.8.3 Middle East and Africa Celecoxib Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Celecoxib Sales by Type (2020-2031)
4.1.1 Global Celecoxib Sales by Type (2020-2025)
4.1.2 Global Celecoxib Sales by Type (2026-2031)
4.1.3 Global Celecoxib Sales Market Share by Type (2020-2031)
4.2 Global Celecoxib Revenue by Type (2020-2031)
4.2.1 Global Celecoxib Revenue by Type (2020-2025)
4.2.2 Global Celecoxib Revenue by Type (2026-2031)
4.2.3 Global Celecoxib Revenue Market Share by Type (2020-2031)
4.3 Global Celecoxib Price by Type (2020-2031)
5 Segment by Application
5.1 Global Celecoxib Sales by Application (2020-2031)
5.1.1 Global Celecoxib Sales by Application (2020-2025)
5.1.2 Global Celecoxib Sales by Application (2026-2031)
5.1.3 Global Celecoxib Sales Market Share by Application (2020-2031)
5.2 Global Celecoxib Revenue by Application (2020-2031)
5.2.1 Global Celecoxib Revenue by Application (2020-2025)
5.2.2 Global Celecoxib Revenue by Application (2026-2031)
5.2.3 Global Celecoxib Revenue Market Share by Application (2020-2031)
5.3 Global Celecoxib Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Pfizer Inc
6.1.1 Pfizer Inc Company Information
6.1.2 Pfizer Inc Description and Business Overview
6.1.3 Pfizer Inc Celecoxib Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Pfizer Inc Celecoxib Product Portfolio
6.1.5 Pfizer Inc Recent Developments/Updates
6.2 Teva
6.2.1 Teva Company Information
6.2.2 Teva Description and Business Overview
6.2.3 Teva Celecoxib Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Teva Celecoxib Product Portfolio
6.2.5 Teva Recent Developments/Updates
6.3 Mylan
6.3.1 Mylan Company Information
6.3.2 Mylan Description and Business Overview
6.3.3 Mylan Celecoxib Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Mylan Celecoxib Product Portfolio
6.3.5 Mylan Recent Developments/Updates
6.4 Apotex
6.4.1 Apotex Company Information
6.4.2 Apotex Description and Business Overview
6.4.3 Apotex Celecoxib Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Apotex Celecoxib Product Portfolio
6.4.5 Apotex Recent Developments/Updates
6.5 Lupin
6.5.1 Lupin Company Information
6.5.2 Lupin Description and Business Overview
6.5.3 Lupin Celecoxib Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Lupin Celecoxib Product Portfolio
6.5.5 Lupin Recent Developments/Updates
6.6 Hengrui Medicine
6.6.1 Hengrui Medicine Company Information
6.6.2 Hengrui Medicine Description and Business Overview
6.6.3 Hengrui Medicine Celecoxib Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Hengrui Medicine Celecoxib Product Portfolio
6.6.5 Hengrui Medicine Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Celecoxib Industry Chain Analysis
7.2 Celecoxib Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Celecoxib Production Mode & Process Analysis
7.4 Celecoxib Sales and Marketing
7.4.1 Celecoxib Sales Channels
7.4.2 Celecoxib Distributors
7.5 Celecoxib Customer Analysis
8 Celecoxib Market Dynamics
8.1 Celecoxib Industry Trends
8.2 Celecoxib Market Drivers
8.3 Celecoxib Market Challenges
8.4 Celecoxib Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
1.1 Product Definition
1.2 Celecoxib by Type
1.2.1 Global Celecoxib Market Value Comparison by Type (2024 VS 2031)
1.2.2 50mg
1.2.3 100mg
1.2.4 200mg
1.2.5 400mg
1.3 Celecoxib by Application
1.3.1 Global Celecoxib Market Value by Application (2024 VS 2031)
1.3.2 Rheumatoid arthritis
1.3.3 osteoarthritis
1.3.4 Acute pain
1.3.5 Musculoskeletal pain
1.3.6 Other diseases
1.4 Global Celecoxib Market Size Estimates and Forecasts
1.4.1 Global Celecoxib Revenue 2020-2031
1.4.2 Global Celecoxib Sales 2020-2031
1.4.3 Global Celecoxib Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Celecoxib Market Competition by Manufacturers
2.1 Global Celecoxib Sales Market Share by Manufacturers (2020-2025)
2.2 Global Celecoxib Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Celecoxib Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Celecoxib, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Celecoxib, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Celecoxib, Product Type & Application
2.7 Global Key Manufacturers of Celecoxib, Date of Enter into This Industry
2.8 Global Celecoxib Market Competitive Situation and Trends
2.8.1 Global Celecoxib Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Celecoxib Players Market Share by Revenue
2.8.3 Global Celecoxib Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Celecoxib Market Scenario by Region
3.1 Global Celecoxib Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Celecoxib Sales by Region: 2020-2031
3.2.1 Global Celecoxib Sales by Region: 2020-2025
3.2.2 Global Celecoxib Sales by Region: 2026-2031
3.3 Global Celecoxib Revenue by Region: 2020-2031
3.3.1 Global Celecoxib Revenue by Region: 2020-2025
3.3.2 Global Celecoxib Revenue by Region: 2026-2031
3.4 North America Celecoxib Market Facts & Figures by Country
3.4.1 North America Celecoxib Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Celecoxib Sales by Country (2020-2031)
3.4.3 North America Celecoxib Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Celecoxib Market Facts & Figures by Country
3.5.1 Europe Celecoxib Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Celecoxib Sales by Country (2020-2031)
3.5.3 Europe Celecoxib Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Celecoxib Market Facts & Figures by Region
3.6.1 Asia Pacific Celecoxib Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Celecoxib Sales by Region (2020-2031)
3.6.3 Asia Pacific Celecoxib Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Celecoxib Market Facts & Figures by Country
3.7.1 Latin America Celecoxib Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Celecoxib Sales by Country (2020-2031)
3.7.3 Latin America Celecoxib Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Celecoxib Market Facts & Figures by Country
3.8.1 Middle East and Africa Celecoxib Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Celecoxib Sales by Country (2020-2031)
3.8.3 Middle East and Africa Celecoxib Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Celecoxib Sales by Type (2020-2031)
4.1.1 Global Celecoxib Sales by Type (2020-2025)
4.1.2 Global Celecoxib Sales by Type (2026-2031)
4.1.3 Global Celecoxib Sales Market Share by Type (2020-2031)
4.2 Global Celecoxib Revenue by Type (2020-2031)
4.2.1 Global Celecoxib Revenue by Type (2020-2025)
4.2.2 Global Celecoxib Revenue by Type (2026-2031)
4.2.3 Global Celecoxib Revenue Market Share by Type (2020-2031)
4.3 Global Celecoxib Price by Type (2020-2031)
5 Segment by Application
5.1 Global Celecoxib Sales by Application (2020-2031)
5.1.1 Global Celecoxib Sales by Application (2020-2025)
5.1.2 Global Celecoxib Sales by Application (2026-2031)
5.1.3 Global Celecoxib Sales Market Share by Application (2020-2031)
5.2 Global Celecoxib Revenue by Application (2020-2031)
5.2.1 Global Celecoxib Revenue by Application (2020-2025)
5.2.2 Global Celecoxib Revenue by Application (2026-2031)
5.2.3 Global Celecoxib Revenue Market Share by Application (2020-2031)
5.3 Global Celecoxib Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Pfizer Inc
6.1.1 Pfizer Inc Company Information
6.1.2 Pfizer Inc Description and Business Overview
6.1.3 Pfizer Inc Celecoxib Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Pfizer Inc Celecoxib Product Portfolio
6.1.5 Pfizer Inc Recent Developments/Updates
6.2 Teva
6.2.1 Teva Company Information
6.2.2 Teva Description and Business Overview
6.2.3 Teva Celecoxib Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Teva Celecoxib Product Portfolio
6.2.5 Teva Recent Developments/Updates
6.3 Mylan
6.3.1 Mylan Company Information
6.3.2 Mylan Description and Business Overview
6.3.3 Mylan Celecoxib Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Mylan Celecoxib Product Portfolio
6.3.5 Mylan Recent Developments/Updates
6.4 Apotex
6.4.1 Apotex Company Information
6.4.2 Apotex Description and Business Overview
6.4.3 Apotex Celecoxib Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Apotex Celecoxib Product Portfolio
6.4.5 Apotex Recent Developments/Updates
6.5 Lupin
6.5.1 Lupin Company Information
6.5.2 Lupin Description and Business Overview
6.5.3 Lupin Celecoxib Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Lupin Celecoxib Product Portfolio
6.5.5 Lupin Recent Developments/Updates
6.6 Hengrui Medicine
6.6.1 Hengrui Medicine Company Information
6.6.2 Hengrui Medicine Description and Business Overview
6.6.3 Hengrui Medicine Celecoxib Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Hengrui Medicine Celecoxib Product Portfolio
6.6.5 Hengrui Medicine Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Celecoxib Industry Chain Analysis
7.2 Celecoxib Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Celecoxib Production Mode & Process Analysis
7.4 Celecoxib Sales and Marketing
7.4.1 Celecoxib Sales Channels
7.4.2 Celecoxib Distributors
7.5 Celecoxib Customer Analysis
8 Celecoxib Market Dynamics
8.1 Celecoxib Industry Trends
8.2 Celecoxib Market Drivers
8.3 Celecoxib Market Challenges
8.4 Celecoxib Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
Table 1. Global Celecoxib Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Celecoxib Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Celecoxib Market Competitive Situation by Manufacturers in 2024
Table 4. Global Celecoxib Sales (K Units) of Key Manufacturers (2020-2025)
Table 5. Global Celecoxib Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Celecoxib Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Celecoxib Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Celecoxib Average Price (US$/Unit) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Celecoxib, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Celecoxib, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Celecoxib, Product Type & Application
Table 12. Global Key Manufacturers of Celecoxib, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Celecoxib by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Celecoxib as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Celecoxib Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Celecoxib Sales by Region (2020-2025) & (K Units)
Table 18. Global Celecoxib Sales Market Share by Region (2020-2025)
Table 19. Global Celecoxib Sales by Region (2026-2031) & (K Units)
Table 20. Global Celecoxib Sales Market Share by Region (2026-2031)
Table 21. Global Celecoxib Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Celecoxib Revenue Market Share by Region (2020-2025)
Table 23. Global Celecoxib Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Celecoxib Revenue Market Share by Region (2026-2031)
Table 25. North America Celecoxib Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Celecoxib Sales by Country (2020-2025) & (K Units)
Table 27. North America Celecoxib Sales by Country (2026-2031) & (K Units)
Table 28. North America Celecoxib Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Celecoxib Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Celecoxib Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Celecoxib Sales by Country (2020-2025) & (K Units)
Table 32. Europe Celecoxib Sales by Country (2026-2031) & (K Units)
Table 33. Europe Celecoxib Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Celecoxib Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Celecoxib Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Celecoxib Sales by Region (2020-2025) & (K Units)
Table 37. Asia Pacific Celecoxib Sales by Region (2026-2031) & (K Units)
Table 38. Asia Pacific Celecoxib Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Celecoxib Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Celecoxib Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Celecoxib Sales by Country (2020-2025) & (K Units)
Table 42. Latin America Celecoxib Sales by Country (2026-2031) & (K Units)
Table 43. Latin America Celecoxib Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Celecoxib Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Celecoxib Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Celecoxib Sales by Country (2020-2025) & (K Units)
Table 47. Middle East and Africa Celecoxib Sales by Country (2026-2031) & (K Units)
Table 48. Middle East and Africa Celecoxib Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Celecoxib Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Celecoxib Sales (K Units) by Type (2020-2025)
Table 51. Global Celecoxib Sales (K Units) by Type (2026-2031)
Table 52. Global Celecoxib Sales Market Share by Type (2020-2025)
Table 53. Global Celecoxib Sales Market Share by Type (2026-2031)
Table 54. Global Celecoxib Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Celecoxib Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Celecoxib Revenue Market Share by Type (2020-2025)
Table 57. Global Celecoxib Revenue Market Share by Type (2026-2031)
Table 58. Global Celecoxib Price (US$/Unit) by Type (2020-2025)
Table 59. Global Celecoxib Price (US$/Unit) by Type (2026-2031)
Table 60. Global Celecoxib Sales (K Units) by Application (2020-2025)
Table 61. Global Celecoxib Sales (K Units) by Application (2026-2031)
Table 62. Global Celecoxib Sales Market Share by Application (2020-2025)
Table 63. Global Celecoxib Sales Market Share by Application (2026-2031)
Table 64. Global Celecoxib Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Celecoxib Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Celecoxib Revenue Market Share by Application (2020-2025)
Table 67. Global Celecoxib Revenue Market Share by Application (2026-2031)
Table 68. Global Celecoxib Price (US$/Unit) by Application (2020-2025)
Table 69. Global Celecoxib Price (US$/Unit) by Application (2026-2031)
Table 70. Pfizer Inc Company Information
Table 71. Pfizer Inc Description and Business Overview
Table 72. Pfizer Inc Celecoxib Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 73. Pfizer Inc Celecoxib Product
Table 74. Pfizer Inc Recent Developments/Updates
Table 75. Teva Company Information
Table 76. Teva Description and Business Overview
Table 77. Teva Celecoxib Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 78. Teva Celecoxib Product
Table 79. Teva Recent Developments/Updates
Table 80. Mylan Company Information
Table 81. Mylan Description and Business Overview
Table 82. Mylan Celecoxib Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 83. Mylan Celecoxib Product
Table 84. Mylan Recent Developments/Updates
Table 85. Apotex Company Information
Table 86. Apotex Description and Business Overview
Table 87. Apotex Celecoxib Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 88. Apotex Celecoxib Product
Table 89. Apotex Recent Developments/Updates
Table 90. Lupin Company Information
Table 91. Lupin Description and Business Overview
Table 92. Lupin Celecoxib Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 93. Lupin Celecoxib Product
Table 94. Lupin Recent Developments/Updates
Table 95. Hengrui Medicine Company Information
Table 96. Hengrui Medicine Description and Business Overview
Table 97. Hengrui Medicine Celecoxib Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 98. Hengrui Medicine Celecoxib Product
Table 99. Hengrui Medicine Recent Developments/Updates
Table 100. Key Raw Materials Lists
Table 101. Raw Materials Key Suppliers Lists
Table 102. Celecoxib Distributors List
Table 103. Celecoxib Customers List
Table 104. Celecoxib Market Trends
Table 105. Celecoxib Market Drivers
Table 106. Celecoxib Market Challenges
Table 107. Celecoxib Market Restraints
Table 108. Research Programs/Design for This Report
Table 109. Key Data Information from Secondary Sources
Table 110. Key Data Information from Primary Sources
Table 111. Authors List of This Report
List of Figures
Figure 1. Product Picture of Celecoxib
Figure 2. Global Celecoxib Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Celecoxib Market Share by Type: 2024 & 2031
Figure 4. 50mg Product Picture
Figure 5. 100mg Product Picture
Figure 6. 200mg Product Picture
Figure 7. 400mg Product Picture
Figure 8. Global Celecoxib Market Value by Application (2020-2031) & (US$ Million)
Figure 9. Global Celecoxib Market Share by Application: 2024 & 2031
Figure 10. Rheumatoid arthritis
Figure 11. osteoarthritis
Figure 12. Acute pain
Figure 13. Musculoskeletal pain
Figure 14. Other diseases
Figure 15. Global Celecoxib Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 16. Global Celecoxib Market Size (2020-2031) & (US$ Million)
Figure 17. Global Celecoxib Sales (2020-2031) & (K Units)
Figure 18. Global Celecoxib Average Price (US$/Unit) & (2020-2031)
Figure 19. Celecoxib Report Years Considered
Figure 20. Celecoxib Sales Share by Manufacturers in 2024
Figure 21. Global Celecoxib Revenue Share by Manufacturers in 2024
Figure 22. Global 5 and 10 Largest Celecoxib Players: Market Share by Revenue in Celecoxib in 2024
Figure 23. Celecoxib Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 24. Global Celecoxib Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 25. North America Celecoxib Sales Market Share by Country (2020-2031)
Figure 26. North America Celecoxib Revenue Market Share by Country (2020-2031)
Figure 27. U.S. Celecoxib Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 28. Canada Celecoxib Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 29. Europe Celecoxib Sales Market Share by Country (2020-2031)
Figure 30. Europe Celecoxib Revenue Market Share by Country (2020-2031)
Figure 31. Germany Celecoxib Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. France Celecoxib Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 33. U.K. Celecoxib Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 34. Italy Celecoxib Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 35. Russia Celecoxib Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 36. Asia Pacific Celecoxib Sales Market Share by Region (2020-2031)
Figure 37. Asia Pacific Celecoxib Revenue Market Share by Region (2020-2031)
Figure 38. China Celecoxib Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. Japan Celecoxib Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. South Korea Celecoxib Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. India Celecoxib Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. Australia Celecoxib Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 43. Taiwan Celecoxib Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 44. Indonesia Celecoxib Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 45. Thailand Celecoxib Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 46. Malaysia Celecoxib Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 47. Philippines Celecoxib Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 48. Latin America Celecoxib Sales Market Share by Country (2020-2031)
Figure 49. Latin America Celecoxib Revenue Market Share by Country (2020-2031)
Figure 50. Mexico Celecoxib Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 51. Brazil Celecoxib Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 52. Argentina Celecoxib Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 53. Middle East and Africa Celecoxib Sales Market Share by Country (2020-2031)
Figure 54. Middle East and Africa Celecoxib Revenue Market Share by Country (2020-2031)
Figure 55. Turkey Celecoxib Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 56. Saudi Arabia Celecoxib Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 57. UAE Celecoxib Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 58. Global Sales Market Share of Celecoxib by Type (2020-2031)
Figure 59. Global Revenue Market Share of Celecoxib by Type (2020-2031)
Figure 60. Global Celecoxib Price (US$/Unit) by Type (2020-2031)
Figure 61. Global Sales Market Share of Celecoxib by Application (2020-2031)
Figure 62. Global Revenue Market Share of Celecoxib by Application (2020-2031)
Figure 63. Global Celecoxib Price (US$/Unit) by Application (2020-2031)
Figure 64. Celecoxib Value Chain
Figure 65. Channels of Distribution (Direct Vs Distribution)
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed
Table 1. Global Celecoxib Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Celecoxib Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Celecoxib Market Competitive Situation by Manufacturers in 2024
Table 4. Global Celecoxib Sales (K Units) of Key Manufacturers (2020-2025)
Table 5. Global Celecoxib Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Celecoxib Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Celecoxib Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Celecoxib Average Price (US$/Unit) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Celecoxib, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Celecoxib, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Celecoxib, Product Type & Application
Table 12. Global Key Manufacturers of Celecoxib, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Celecoxib by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Celecoxib as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Celecoxib Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Celecoxib Sales by Region (2020-2025) & (K Units)
Table 18. Global Celecoxib Sales Market Share by Region (2020-2025)
Table 19. Global Celecoxib Sales by Region (2026-2031) & (K Units)
Table 20. Global Celecoxib Sales Market Share by Region (2026-2031)
Table 21. Global Celecoxib Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Celecoxib Revenue Market Share by Region (2020-2025)
Table 23. Global Celecoxib Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Celecoxib Revenue Market Share by Region (2026-2031)
Table 25. North America Celecoxib Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Celecoxib Sales by Country (2020-2025) & (K Units)
Table 27. North America Celecoxib Sales by Country (2026-2031) & (K Units)
Table 28. North America Celecoxib Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Celecoxib Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Celecoxib Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Celecoxib Sales by Country (2020-2025) & (K Units)
Table 32. Europe Celecoxib Sales by Country (2026-2031) & (K Units)
Table 33. Europe Celecoxib Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Celecoxib Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Celecoxib Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Celecoxib Sales by Region (2020-2025) & (K Units)
Table 37. Asia Pacific Celecoxib Sales by Region (2026-2031) & (K Units)
Table 38. Asia Pacific Celecoxib Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Celecoxib Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Celecoxib Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Celecoxib Sales by Country (2020-2025) & (K Units)
Table 42. Latin America Celecoxib Sales by Country (2026-2031) & (K Units)
Table 43. Latin America Celecoxib Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Celecoxib Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Celecoxib Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Celecoxib Sales by Country (2020-2025) & (K Units)
Table 47. Middle East and Africa Celecoxib Sales by Country (2026-2031) & (K Units)
Table 48. Middle East and Africa Celecoxib Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Celecoxib Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Celecoxib Sales (K Units) by Type (2020-2025)
Table 51. Global Celecoxib Sales (K Units) by Type (2026-2031)
Table 52. Global Celecoxib Sales Market Share by Type (2020-2025)
Table 53. Global Celecoxib Sales Market Share by Type (2026-2031)
Table 54. Global Celecoxib Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Celecoxib Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Celecoxib Revenue Market Share by Type (2020-2025)
Table 57. Global Celecoxib Revenue Market Share by Type (2026-2031)
Table 58. Global Celecoxib Price (US$/Unit) by Type (2020-2025)
Table 59. Global Celecoxib Price (US$/Unit) by Type (2026-2031)
Table 60. Global Celecoxib Sales (K Units) by Application (2020-2025)
Table 61. Global Celecoxib Sales (K Units) by Application (2026-2031)
Table 62. Global Celecoxib Sales Market Share by Application (2020-2025)
Table 63. Global Celecoxib Sales Market Share by Application (2026-2031)
Table 64. Global Celecoxib Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Celecoxib Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Celecoxib Revenue Market Share by Application (2020-2025)
Table 67. Global Celecoxib Revenue Market Share by Application (2026-2031)
Table 68. Global Celecoxib Price (US$/Unit) by Application (2020-2025)
Table 69. Global Celecoxib Price (US$/Unit) by Application (2026-2031)
Table 70. Pfizer Inc Company Information
Table 71. Pfizer Inc Description and Business Overview
Table 72. Pfizer Inc Celecoxib Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 73. Pfizer Inc Celecoxib Product
Table 74. Pfizer Inc Recent Developments/Updates
Table 75. Teva Company Information
Table 76. Teva Description and Business Overview
Table 77. Teva Celecoxib Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 78. Teva Celecoxib Product
Table 79. Teva Recent Developments/Updates
Table 80. Mylan Company Information
Table 81. Mylan Description and Business Overview
Table 82. Mylan Celecoxib Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 83. Mylan Celecoxib Product
Table 84. Mylan Recent Developments/Updates
Table 85. Apotex Company Information
Table 86. Apotex Description and Business Overview
Table 87. Apotex Celecoxib Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 88. Apotex Celecoxib Product
Table 89. Apotex Recent Developments/Updates
Table 90. Lupin Company Information
Table 91. Lupin Description and Business Overview
Table 92. Lupin Celecoxib Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 93. Lupin Celecoxib Product
Table 94. Lupin Recent Developments/Updates
Table 95. Hengrui Medicine Company Information
Table 96. Hengrui Medicine Description and Business Overview
Table 97. Hengrui Medicine Celecoxib Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 98. Hengrui Medicine Celecoxib Product
Table 99. Hengrui Medicine Recent Developments/Updates
Table 100. Key Raw Materials Lists
Table 101. Raw Materials Key Suppliers Lists
Table 102. Celecoxib Distributors List
Table 103. Celecoxib Customers List
Table 104. Celecoxib Market Trends
Table 105. Celecoxib Market Drivers
Table 106. Celecoxib Market Challenges
Table 107. Celecoxib Market Restraints
Table 108. Research Programs/Design for This Report
Table 109. Key Data Information from Secondary Sources
Table 110. Key Data Information from Primary Sources
Table 111. Authors List of This Report
List of Figures
Figure 1. Product Picture of Celecoxib
Figure 2. Global Celecoxib Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Celecoxib Market Share by Type: 2024 & 2031
Figure 4. 50mg Product Picture
Figure 5. 100mg Product Picture
Figure 6. 200mg Product Picture
Figure 7. 400mg Product Picture
Figure 8. Global Celecoxib Market Value by Application (2020-2031) & (US$ Million)
Figure 9. Global Celecoxib Market Share by Application: 2024 & 2031
Figure 10. Rheumatoid arthritis
Figure 11. osteoarthritis
Figure 12. Acute pain
Figure 13. Musculoskeletal pain
Figure 14. Other diseases
Figure 15. Global Celecoxib Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 16. Global Celecoxib Market Size (2020-2031) & (US$ Million)
Figure 17. Global Celecoxib Sales (2020-2031) & (K Units)
Figure 18. Global Celecoxib Average Price (US$/Unit) & (2020-2031)
Figure 19. Celecoxib Report Years Considered
Figure 20. Celecoxib Sales Share by Manufacturers in 2024
Figure 21. Global Celecoxib Revenue Share by Manufacturers in 2024
Figure 22. Global 5 and 10 Largest Celecoxib Players: Market Share by Revenue in Celecoxib in 2024
Figure 23. Celecoxib Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 24. Global Celecoxib Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 25. North America Celecoxib Sales Market Share by Country (2020-2031)
Figure 26. North America Celecoxib Revenue Market Share by Country (2020-2031)
Figure 27. U.S. Celecoxib Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 28. Canada Celecoxib Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 29. Europe Celecoxib Sales Market Share by Country (2020-2031)
Figure 30. Europe Celecoxib Revenue Market Share by Country (2020-2031)
Figure 31. Germany Celecoxib Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. France Celecoxib Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 33. U.K. Celecoxib Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 34. Italy Celecoxib Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 35. Russia Celecoxib Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 36. Asia Pacific Celecoxib Sales Market Share by Region (2020-2031)
Figure 37. Asia Pacific Celecoxib Revenue Market Share by Region (2020-2031)
Figure 38. China Celecoxib Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. Japan Celecoxib Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. South Korea Celecoxib Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. India Celecoxib Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. Australia Celecoxib Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 43. Taiwan Celecoxib Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 44. Indonesia Celecoxib Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 45. Thailand Celecoxib Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 46. Malaysia Celecoxib Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 47. Philippines Celecoxib Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 48. Latin America Celecoxib Sales Market Share by Country (2020-2031)
Figure 49. Latin America Celecoxib Revenue Market Share by Country (2020-2031)
Figure 50. Mexico Celecoxib Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 51. Brazil Celecoxib Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 52. Argentina Celecoxib Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 53. Middle East and Africa Celecoxib Sales Market Share by Country (2020-2031)
Figure 54. Middle East and Africa Celecoxib Revenue Market Share by Country (2020-2031)
Figure 55. Turkey Celecoxib Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 56. Saudi Arabia Celecoxib Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 57. UAE Celecoxib Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 58. Global Sales Market Share of Celecoxib by Type (2020-2031)
Figure 59. Global Revenue Market Share of Celecoxib by Type (2020-2031)
Figure 60. Global Celecoxib Price (US$/Unit) by Type (2020-2031)
Figure 61. Global Sales Market Share of Celecoxib by Application (2020-2031)
Figure 62. Global Revenue Market Share of Celecoxib by Application (2020-2031)
Figure 63. Global Celecoxib Price (US$/Unit) by Application (2020-2031)
Figure 64. Celecoxib Value Chain
Figure 65. Channels of Distribution (Direct Vs Distribution)
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Fully Automatic Vehicle Disinfection Equipment Market Research Report 2026
Mar 14, 26
Global Heat Resistant FPC Market Research Report 2026
Mar 14, 26
Global Portable Recording Stick Market Research Report 2026
Mar 14, 26
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232